Skip to main content
Filing year 2023

A Cure in Sight

Raleigh, North Carolina·EIN 46-1274306·NTEE H12 · Medical Research·501(c)(3)
Total revenue
$409k
Total assets
$197k
Total expenses
$491k
Reported officers
4
Mission

A Cure in Sight's mission is to provide funding for patient services for ocular melanoma eye cancer patients education awareness and research.

Reported officers (all unpaid)

No paid executives reported in 2023. A Cure in Sight reported 4 unpaid officers and board members on its 990.

President
Secretary
Treasurer
Vice President

Funded by

Private foundations whose Form 990-PF Part XV grants matched this organization.

Sector benchmark

What Medical Research executives earn

A Cure in Sight reported no executive compensation in its latest filing. For context, the highest-paid executive at a comparable medical research organization nationwide earns a median of $120,264.

25th percentile
$48k
Median
$120,264
75th percentile
$252k
90th percentile
$466k

These are medical research sector-wide figures, not this organization's reported pay. Based on 1,118 organizations across 1,118 filings (2020 – 2024).

See full Medical Research compensation data
FAQ

Common questions about A Cure in Sight

What are A Cure in Sight's revenue and expenses?

In 2023, A Cure in Sight reported $409k in total revenue and $491k in total expenses on its IRS Form 990.

Free, forever
Build lists. Save your benchmarks.
A free Lucido account lets you build lists of nonprofits and save your search filters. No credit card.
Already a member? Sign in
Build a benchmark

Compare any role, sector, or revenue band

Build your own benchmark from millions of reported positions.